Pretransplant Evaluation and Care

Zakim and Boyer's Hepatology

Volumn , Issue , 2006, Pages 933-945

  Ahmed, Aijaz ^a   Keeffe, Emmet B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649389761     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3258-8.50054-1     Document Type: Chapter

References (109)

1. Keeffe EB Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001, 120:749-762.
2. Smith CM, Davies DB, McBride MA Liver transplantation in the United States: A report from the Organ Procurement and Transplantation Network. Clinical transplants 1998 2001, 19-30. UCLA Tissue Typing Laboratory, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
3. Yu AS, Ahmed A, Keeffe EB Liver transplantation: evolving patient selection criteria. Can J Gastroenterol 2001, 15:729-738.
4. Wiesner RH, Rakela J, Ishitani MB, et al. Recent advances in liver transplantation. Mayo Clin Proc 2003, 78:197-210.
5. US Scientific Registry (UNOS). Richmond, VA: United Network for Organ Sharing, 2003. . http://www.unos.org.
6. Showstack J, Katz PP, Lake JR, et al. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. JAMA 1999, 281:1381-1386.
7. Gilbert JR, Pascual M, Schoenfeld DA, et al. Evolving trends in liver transplantation: an outcome and charge analysis. Transplantation 1999, 67:246-253.
8. Onaca NN, Levy MF, Sanchez EQ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003, 9:117-123.
9. Onaca NN, Levy MF, Netto GJ, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003, 3:626-630.
10. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003, 9:473-476.
11. Nair S, Verma S, Thuluvath PJ Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002, 35:1179-1185.
12. Seaberg EC, Belle SH, Beringer KC, et al. Liver transplantation in the United States from 1987-1998: Updated results from the Pitt-UNOS liver transplant registry. Clinical transplants 1998 1999, 17-37. UCLA Tissue Typing Laboratory, Los Angeles. J.M. Cecka, P.I. Terasaki (Eds.).
13. Roberts MS, Angus DC, Bryce CL, et al. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004, 10:886-897.
14. Bravata DM, Olkin I, Barnato AE, et al. Health-related quality of life after liver transplantation: A meta-analysis. Liver Transpl Surg 1999, 5:318-331.
15. McDiarmid SV Liver transplantation for metabolic disease. Transplantation of the liver 1996, 198-215. WB Saunders, Philadelphia. R.W. Busuttil, G.B. Klintmalm (Eds.).
16. Keeffe EB Selection of patients for liver transplantation. Transplantation of the liver 2001, 5-34. Lippincott Williams & Wilkins, Philadelphia. 3rd edn. W.C. Maddrey, E.R. Schiff, M.F. Sorrell (Eds.).
17. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97:439-445.
18. Bernuau J, Samuel D, Durand F, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study [Abstract]. Hepatology 1991, 14:49A.
19. Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6:163-169.
20. Riordan SM, Williams R Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000, 6:170-173.
21. Steinmuller T, Jonas S, Neuhaus P. Review article: liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther 2003, 17(Suppl 2):138-144.
22. Sarasin FP, Giostra E, Mentha G, et al. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998, 28:436-442.
23. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
24. Harnois DM, Steers J, Andrews JC, et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 1999, 5:192-199.
25. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991, 110:726-734.
26. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997, 26:877-883.
27. Menon KV, Shah V, Kamath PS The Budd-Chiari syndrome. N Engl J Med 2004, 350:578-585.
28. Orug T, Soonawalla ZF, Tekin K, et al. Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation. Br J Surg 2004, 91:769-773.
29. Sherlock S. Cystic diseases of the liver. Schiff's Diseases of the liver 1999, 1083-1090. Lippincott-Raven, Philadelphia. 8th edn. E.R. Schiff, M.F. Sorrell, W.C. Maddrey (Eds.).
30. Pirenne J, Aerts R, Yoong K, et al. Liver transplantation for polycystic liver disease. Liver Transpl 2001, 7:238-245.
31. Lim JK, Keeffe EB Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl 2004, 10(Suppl):S31-S38.
32. Bravata DM, Olkin I, Barnato AE, et al. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 2001, 7:191-203.
33. Pageaux GP, Michel J, Coste V, et al. Alcoholic cirrhosis is a good indication for liver transplantation even for cases of recidivism. Gut 1999, 45:421-426.
34. Keswani RN, Ahmed A, Keeffe EB Older age and liver transplantation: a review. Liver Transpl 2004, 10:957-967.
35. Nair S, Cohen DB, Cohen MP, et al. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001, 96:842-845.
36. Keeffe EB, Gettys C, Esquivel CO Liver transplantation in patients with severe obesity. Transplantation 1994, 57:309-311.
37. Nair S, Verma S, Thuluvath PJ Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002, 35:105-109.
38. Carithers RL Liver transplantation American Association for the Study of Liver Diseases. Liver Transpl 2000, 6:122-135.
39. Rosen HR, Martin P Liver transplantation. Schiff's Diseases of the liver 1999, 1589-1615. Lippincott-Raven, Philadelphia. 8th edn. E.R. Schiff, M.F. Sorrell, W.C. Maddrey (Eds.).
40. Keeffe EB Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation. Liver Transpl Surg 1997, 3:251-257.
41. Plotkin JS, Johnson LB, Rustgi V, et al. Coronary artery disease and liver transplantation: the state of the art. Liver Transpl 2000, 6:S53-S56.
42. Keeffe BG, Valantine H, Keeffe EB Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001, 7:755-761.
43. Eckhoff DE, Frenette L, Sellers MT, et al. Combined cardiac surgery and liver transplantation. Liver Transpl 2001, 7:60-61.
44. Pham PT, Pham PC, Wilkinson AH The kidney in liver transplantation. Clin Liver Dis 2000, 4:567-590.
45. Brown RS, Lombardero M, Lake JR Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996, 62:1788-1793.
46. Wiesner RH Current indications, contraindications, and timing for liver transplantation. Transplantation of the liver 1996, 71-84. WB Saunders, Philadelphia. R.W. Busuttil, G.B. Klintmalm (Eds.).
47. Chaparro SV, Montoya JG, Keeffe EB, et al. Risk of tuberculosis in tuberculin skin-positive liver transplant patients. Clin Infect Dis 1999, 29:207-208.
48. Krowka MJ Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl 2000, 6:S31-S35.
49. Krowka MJ, Porayko MK, Plevak DJ, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997, 72:44-53.
50. Egawa H, Kasahara M, Inomata Y, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999, 67:712-717.
51. Ramsay MA, Simpson BR, Nguyen AT, et al. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997, 3:494-500.
52. Pilatis ND, Jacobs LE, Rerkpattanapipat P, et al. Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation. Liver Transpl 2000, 6:85-91.
53. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 2000, 6:453-458.
54. Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000, 6:443-450.
55. Kuo PC, Johnson LB, Plotkin JS, et al. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997, 63:604-606.
56. Fung J, Eghtesad B, Patel-Tom K, et al. Liver transplantation in patients with HIV infection. Liver Transpl 2004, 10(Suppl):S39-S53.
57. Berenguer M, Lopez-Labrador FX, Greenberg HB, et al. Hepatitis C virus and the host: An imbalance induced by immunosuppression?. Hepatology 2000, 32:433-435.
58. Rosen HR, Martin P Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998, 66:1612-1616.
59. Sheiner PA, Schluger LK, Emre S, et al. Retransplantation for recurrent hepatitis C. Liver Transpl Surg 1997, 3:130-136.
60. Moreno Gonzalez E, Garcia Garcia I, Gomez Sanz R, et al. Liver transplantation in patients with thrombosis of the portal, splenic or superior mesenteric vein. Br J Surg 1993, 80:81-85.
61. Manzanet G, Sanjuan F, Orbis P, et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 2001, 7:125-131.
62. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998, 87:358-364.
63. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000, 6:309-316.
64. Pichlmayr R, Weimann A, Oldhafer KJ, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995, 19:807-813.
65. Saigal S, Norris S, Srinivasan P, et al. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states. Liver Transpl 2001, 7:11-15.
66. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993, 55:742-747.
67. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians an the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997, 3:628-637.
68. Roll J, Boyer JL, Barry D, et al. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983, 308:1-7.
69. Markus BH, Dickson ER, Grambsch PM, et al. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989, 320:1709-1713.
70. Wiesner RH, Porayko MK, Dickson ER, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992, 16:1290-1299.
71. Kim WR, Wiesner RH, Therneau TM, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998, 28:33-38.
72. Kim WR, Wiesner RH, Poterucha JJ, et al. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000, 6:489-494.
73. Kim WR, Therneau TM, Wiesner RH, et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 2000, 75:688-694.
74. Talwalkar JA, Seaberg E, Kim WR, et al. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl 2000, 6:753-758.
75. Child CG, Turcotte JG Surgery and portal hypertension. Major Probl Clin Surg 1964, 1:1-85.
76. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding esophageal varices. Br J Surg 1973, 60:649-654.
77. Propst A, Propst T, Zangerl G, et al. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995, 40:1805-1815.
78. Yu AS, Keeffe EB Orthotopic liver transplantation. Hepatology 2002, 1617-1656. Harcourt Health Sciences, Philadelphia. 4th edn. T. Boyer, D. Zakim (Eds.).
79. Dyer PA, Bobrow M Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy Unrelated Live Transplant Regulatory Authority (ULTRA). Transplantation 1999, 67:1202.
80. Sterling RK, Fisher RA Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis 2001, 5:431-460.
81. Bzeizi KI, Jalan R, Plevris JN, et al. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transpl Surg 1997, 3:137-148.
82. Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996, 62:1246-1251.
83. Detre KM, Lombardero M, Belle S, et al. Influence of donor age on graft survival after transplantation - United Network for Organ Sharing Registry. Liver Transpl Surg 1995, 1:311-319.
84. Dodson SF, Bonham CA, Geller DA, et al. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999, 68:1058-1061.
85. Holt D, Thomas R, Van Thiel D, et al. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. Arch Surg 2002, 137:572-575.
86. Loss GE, Mason AL, Blazek J, et al. Transplantation of livers from HBc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results. Clin Transpl 2001, 15:55-58.
87. Vargas HE, Laskus T, Wang LF, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999, 117:149-153.
88. Marroquin CE, Marino G, Kuo PC, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001, 7:762-768.
89. Velidedeoglu E, Desai NM, Campos L, et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002, 73:582-587.
90. Busuttil RW, Goss JA Split liver transplantation. Ann Surg 1999, 229:313-321.
91. Rela M, Vougas V, Muiesan P, et al. Split liver transplantation: King's College Hospital experience. Ann Surg 1998, 227:282-288.
92. Ghobrial RM, Yersiz H, Farmer DG, et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000, 232:312-323.
93. Michalopoulos GK, DeFrances MC Liver regeneration. Science 1997, 276:60-66.
94. Shiffman ML, Brown RS, Olthoff KM, et al. Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl 2002, 8:174-188.
95. Hashikura Y, Makuuchi M, Kawasaki S, et al. Successful living-related partial liver transplantation to an adult patient. Lancet 1994, 343:1233-1234.
96. Marcos A, Ham JM, Fisher RA, et al. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000, 6:296-301.
97. Marcos A. Right lobe living donor liver transplantation: a review. Liver Transpl 2000, 6:3-20.
98. Trotter JF, Wachs M, Trouillot T, et al. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000, 6:290-295.
99. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001, 34:46-52.
100. Freeman RB, Wiesner RH, Harper A, et al. and UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002, 8:851-858.
101. Ubel PA Geographic favoritism in liver transplantation - unfortunate or unfair?. N Engl J Med 1998, 339:1322-1325.
102. Organ procurement and transplantation network - HRSA. Final rule with comment period. Fed Reg 1998, 63:16296-16338. National Institutes of Health Consensus Development Conference Statement.
103. Analysis of waiting time. Committee on Organ Transplantation. Assessing current policies and the potential impact of the DHHS final rule 1999, 57-78. National Institutes of Health Consensus Development Conference Statement, National Academy Press, Washington, DC.
104. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31:864-871.
105. Forman LM, Lucey MR Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001, 33:473-475.
106. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001, 7:567-580.
107. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
108. Wiesner R, Edwards E, Freeman R, et al. The United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
109. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004, 10:7-15.